Messenger RNA (mRNA) Vaccines
The mRNA vaccines are considered a new product in vaccine technology, using genetic material that initiates the body's immune response against specific diseases. Unlike other types of vaccines, which can use live or killed pathogens, mRNA vaccines deliver the blueprint to cells, allowing the body to produce proteins associated with a virus and elicit an immune response.
mRNA vaccines introduce a small piece of messenger RNA into the body. The mRNA carries a message to the cells to make a protein that is found on the surface of this virus. For example, for COVID-19 vaccines, the mRNA coded for the spike protein specific to the SARS-CoV-2 virus. When cells in the body start making the spike protein, this is recognized by the immune system as foreign, prompting an immune response and hence leading to immunity.
Most importantly, the mRNA does not penetrate into the cell's nucleus and is not able to modify DNA, so its activity is only limited to the desired immune response. mRNA vaccines can be developed relatively fast. Conventional vaccines may take years to develop. Comparatively, mRNA vaccines have an easier design and manufacturing process once the sequence of a pathogen is understood. This adaptability makes mRNA technology invaluable in counteracting emerging infectious diseases-fast development of COVID-19 vaccines could be cited as an example.
Moreover, mRNA vaccines have high flexibility and scalability. They can be used in a platform to target diverse pathogens, which may simplify the production of vaccines for other infectious diseases. This ease of making changes if a virus happens to mutate means that updates can be made quickly enough to ensure effectiveness.
As research in mRNA vaccines continues, these may hold great promise in the treatment of a wide spectrum of diseases, from infectious diseases to potentially the very first treatments that could be used in cancer immunotherapy. Thus, mRNA vaccines represent one of the most important steps in advancing personalized medicine and public health by enabling the immune system to target specific proteins.
Other Relevant Topics
Media Partners
Partnered Content Networks
Engage in the Vaccines Global Summit where the world's leading experts in vaccine technology and global researchers meet to discuss and generate ideas that advance the success of immunization.